Structure-Bioactivity Relationships of Bacterial Endotoxins

References

• Rietschel E. T., Kirikae T., Schade U. F., Mamat U., Schmidt G., Loppnow H., Ulmer A., Seydel U., Di Padova F., Schreier M., Brade H. Bacterial Endotoxin: Molecular Relationships of Structure to Activity and Function. FASEB J. 1994; 8: 217
   PubMed Web of Science ®Google Scholar
• Rietschel E. T., Brade L., Schade U., Seydel U., Zá Uhringer U., Holst O., Kuhn H.-M., Kulschin V. A., Moran A. P., Brade H. FEMS Symposium No.51: Microbial Surface Components and Toxins in Relation to Pathogenesis, E. Z. Ron. Plenum Publishing Corporation, New York 1991; 209
   Google Scholar
• Rietschel E. T., Brade L., Holst O., Kulshin V. A., Lindner B., Moran A. P., Schade U., Uhringer U., Brade H. Endotoxin Research Series, Vol. 1: Cellular and Molecular Aspects of Endotoxin Reactions, J. J. Spitzer, E. J. Ziegler. Elsevier Science Publishers B.V., Amsterdam 1990; 15
   Google Scholar
• Moran A. P., Kuusela P., Kosunen T. U. Interaction of Helicobacter pylori with Extracellular Matrix Proteins. J. Appl. Bacteriol. 1993; 75: 184
   Google Scholar
• Valkonen K., Wadstro Um T., Moran A. P. Interaction of Lipopolysaccharides of Helicobacter pylori with Basement Membrane Protein Laminin. Infect. Immun. 1994; 62: 3640
   PubMedGoogle Scholar
• Slomiany B. L., Piotrowski J., Rajiah G., Slomiany A. Inhibition of Gastric Mucosal Laminin Receptor by Helicobacter pylori Lipopolysaccharide: Effect of Nitecapone. Gen. Pharmacol. 1991; 22: 1063
   PubMedGoogle Scholar
• Slomiany B., Lí Aau Y. H., Lopez R. A., Piotrowski J., Czajkowski A., Slomiany A. Effect of Helicobacter pylori on the Synthesis of Sulfated Gastric Mucin. Biochem. Int. 1992; 27: 687
   PubMedGoogle Scholar
• Young G. O., Stemmet N., Lastovica A., van der Merwe E. L., Louw J. A., Modlin I. M., Marks I. N. Helicobacter pylori Lipopolysaccharide Stimulates Gastric Mucosal Pepsinogen Secretion. Aliment. Pharmacol. Ther. 1992; 6: 169
   PubMed Web of Science ®Google Scholar
• Moran A. P. Cell Surface Characteristics of Helicobacter pylori. FEMS Immunol. Med. Microbiol.
   Google Scholar
• Lee A., Moran A. P. Helicobacter pylori: Basic Mechanisms to Clinical Cure, R. H. Hunt, G. N.J. Tytgat. Kluwer Academic Publishers, Dordrecht 1994; 169
   Google Scholar
• Morrison D. C., Ryan J. L. Endotoxins and Disease Mechanisms. Annu. Rev. Med. 1987; 38: 417
   PubMed Web of Science ®Google Scholar
• Glauser M. P., Zanetti G., Baumgartner J., Cohen J. Septic Shock: Pathogenesis. Lancet 1991; 338: 732
   PubMed Web of Science ®Google Scholar
• Rietschel E. T., Brade H. Bacterial Endotoxins. Sci. Amer. 1992; 267: 54
   PubMed Web of Science ®Google Scholar
• Corriveau C. C., Danner R. L. Endotoxin as a Therapeutic Target in Septic Shock. Infect. Agents Dis. 1993; 2: 35
   PubMedGoogle Scholar
• Morrison D. C., Danner R. L., Munford R. S., Natanson C., Pollack M., Spitzer J. J., Ulevitch R. J., Vogel S., Mc Sweegan E. Bacterial Endotoxins and Pathogenesis of Gram-Negative Infections: Current Status and Future Direction. J. Endotoxin Res. 1994; 1: 71
   Google Scholar
• Suffredini A. F., Fromm R. E., Parker M. M., Brenner M., Kovacs J. A., Wesley R. A., Parrillo J. E. The Cardiovascular Response of Normal Humans to the Administration of Endotoxin. N. Engl. J. Med. 1989; 321: 280
   PubMed Web of Science ®Google Scholar
• Natanson C., Eichenholz P. W., Danner R. L., Eichacker P. Q., Hoffman W. D., Kuo G. C., Banks S., Vittie T. J., Parrillo J. E. Endotoxin and Tumor Necrosis Factor Challenges in Dogs Simulate the Cardiovascular Profile of Human Septic Shock. J. Exp. Med. 1991; 173: 1021
   PubMedGoogle Scholar
• Martich G. D., Danner R., Ceska M., Suffredini A. F. Detection of Interleukin 8 and Tumor Necrosis Factor in Normal Humans after Intravenous Endotoxin: the Effect of Antiinflammatory Agents. J. Exp. Med. 1991; 173: 1021
   PubMed Web of Science ®Google Scholar
• Brues A. M., Shear M. Chemical Treatment of Tumors. X.Reactions of Four Patients with Advanced Malignant Tumours to Injection of a Polysaccharide from Serratia marcescens Culture Filtrate. JNCI 1944; 5: 195
   Google Scholar
• Stevens A. R., Legg J. S., Henry B. S., Dille J. M., Kirby W. M.M., Finch C. A. Fatal Transfusion Reactions from Contamination of Stored Blood by Cold Growing Bacteria. Ann. Intern. Med. 1228; 39: 1228
   Google Scholar
• Natanson C., Danner R. L., Reilly J. M., Doerfler M. L., Hoffman W. D., Akin G. L., Hosseini J. M., Banks S. M., Elin R., Vittie T. J., Parrillo J. E. Antibiotics Versus Cardiovascular Support in a Canine Model of Human Septic Shock. Am. J. Physiol. 1990; 259: H1440
   Google Scholar
• Brandtzaeg P., Kierulf P., Gaustad P., Skulberg A., Bruun J. N., Halvorsen S., Sorensen E. Plasma Endotoxin as a Predictor of Multiple Organ Failure and Death in Systemic Meningococcal Disease. J. Infect. Dis. 1989; 159: 195
   PubMed Web of Science ®Google Scholar
• Van Deventer S., Buller H., Cate J. W., Sturk A., Pauw W. Endotoxaemia: an Early Predictor of Septicaemia in Febrile Patients. Lancet 1988; 1: 605
   PubMed Web of Science ®Google Scholar
• Danner, Elin R. L., Wesley J. M., Reilly J. M., Parrillo J. E. Endotoxemia in Human Septic Shock. Chest 1991; 99: 169
   PubMed Web of Science ®Google Scholar
• Natanson C., Danner R. L., Elin R. J., Hosseini J. M., Peart K., Mac Vittie T. J., Walker R. I., Parillo J. E. Role of Endotoxemia in Cardiovascular Dysfunction and Mortality: Ecoli and Saureus Challenges in a Canine Model of Human Septic Shock. J. Clin. Invest. 243; 83: 243
   Google Scholar
• Hoffman W. D., Natanson C., Danner R. L., Koev L., Banks S. M., Elin R. J., Hosseini J. M., Parrillo J. E. Bacterial Organism Virulence Factors May Be More Important than Endotoxemia in Determining Cardiovascular (CV) Dysfunction and Mortality in Canine Septic Shock. Clin. Res. 1989; 37: 344
   Google Scholar
• Hoffman W. D., Danner R. L., Koev L., Banks S., Walker L. D., Elin R. J., Hosseini J. M., Dolan D. P., Natanson C. Ability of Endotoxin and Heat Stable Components of Two Strains of Ecoli to Produce Lethality in Canine Septic Shock. Clin. Res. 1990; 38: 454
   Google Scholar
• Rietschel E. T., Brade L., Lindner B., Zá Uhringer U. Bacterial Endotoxic Lipopolysaccharides, Vol. 1: Molecular Biochemistry and Cellular Biology, D. C. Morrison, J. L. Ryan. CRC Press, Boca Raton 1992; 3
   Google Scholar
• Aspinall G., Mc Donald A. G., Raju T. S., Pang H., Moran A. P., Penner J. L. Chemical Structure of the Core Regions of Campylobacter jejuni Serotypes 0:1, 0:4, 0:23, and 0:36 Lipopolysaccharides. Eur. J. Biochem. 1993; 213: 1017
   PubMedGoogle Scholar
• Aspinall G., Mc Donald A. G., Raju T. S., Pang H., Penner J. L., Moran A. P. Chemical Structure of the Core Region of Campylobacter jejuni Serotype 0:2 Lipopolysaccharide. Eur. J. Biochem. 1993; 213: 1029
   PubMedGoogle Scholar
• Aspinall G. O., Monteiro M. A., Pang H., Walsh E. J., Moran A. P. O Antigen Chains in the Lipopolysaccharide of Helicobacter pylori NCTC 11637. Carbohydr, Lett
   Google Scholar
• Hase S., Rietschel E. T. Isolation and Analysis of the Lipid A Backbone: Lipid A Structure of Lipopolysaccharides from Various Bacterial Groups. Eur. J. Biochem. 1976; 63: 101
   PubMedGoogle Scholar
• Rosner M. R., Khorana H. G., Satterthwait A. C. The Structure of Lipopolysaccharide from a Heptose-less Mutant of Escherichia coli K-12: II The Application of 31P NMR Spectroscopy. J. Biol. Chem. 1979; 254: 5918
   Google Scholar
• Strain S. M., Fesik S. W., Armitage J. M. Characterization of Lipopolysaccharide from a Heptoseless Mutant of Escherichia coli by Carbon 13 Nuclear Magnetic Resonance. J. Biol. Chem. 1983; 258: 2906
   PubMedGoogle Scholar
• Strain S. M., Fesik S. W., Armitage I. M. Structure and Metal-Binding Properties of Lipopolysaccharides from Heptoseless Mutants of Escherichia coli: Studies by 13C and 31P Nuclear Magnetic Resonance. J. Biol. Chem. 1983; 258: 13466
   PubMedGoogle Scholar
• Imoto M., Kusumoto S., Shiba I., Naoki H., Iwashita T., Rietschel E. T., Wollenweber H.-W., Galanos C., Lüderitz O. Chemical Structure of Ecoli Lipid A: Linkage Site of Acyl Groups in the Disaccharide Backbone. Tetrahedron Lett. 1983; 24: 4017
   Google Scholar
• Wollenweber H.-W., Seydel U., Lindner B., Uderitz O., Rietschel E. T. Nature and Location of Amide-Bound (R)-3-Acyloxylacyl Groups in Lipid A of Lipopolysaccharides From Various Gram-Negative Bacteria. Eur. J. Biochem. 1984; 145: 265
   PubMedGoogle Scholar
• Rietschel E. T., Gottert H., Lü Uderitz O., Westphal O. Nature and Linkages of the Fatty Acids Present in the Lipid-A Component of Salmonella Lipopolysaccharides. Eur. J. Biochem. 1972; 28: 166
   PubMedGoogle Scholar
• Seydel U., Lindner B., Wollenweber H., Rietschel E. T. Structural Studies on the Lipid A Component of Enterobacterial Lipopolysaccharides by Laser Desorption Mass Spectrometry: Location of Acyl Groups at the Lipid A Backbone. Eur. J. Biochem. 1984; 145: 505
   PubMedGoogle Scholar
• Imoto M., Kusumoto S., Shiba T., Rietschel E. T., Galanos C., Lüderitz O. Chemical Structure of Escherichia coli Lipid A. Tetrahedron Lett. 1985; 26: 907
   Web of Science ®Google Scholar
• Qureshi N., Takayama K., Mascagni P., Honovich J., Wong R., Cotter R. J. Complete Structural Determination of Lipopolysaccharide Obtained from Deep Rough Mutant of Escherichia coli. J. Biol. Chem. 1988; 263: 11971
   PubMedGoogle Scholar
• Rietschel E. T., Wollenweber H.-W., Brade H., Uhringer U., Lindner B., Seydel U., Bradaczek H., Barnickel G., Labischinski H., Giesbrecht P. Handbook of Endotoxin, Vol. 1: Chemistry of Endotoxin, E. T. Rietschel. Elsevier Science Publishers B.V., Amsterdam 1984; 187
   Google Scholar
• Gmeiner J., Uderitz O., Westphal O. Biochemical Studies on Lipopolysaccharides of Salmonella R Mutants. 6. Investigations on the Structure of the Lipid A Component. Eur. J. Biochem. 1969; 7: 370
   PubMedGoogle Scholar
• Batley M., Packer N. H., Redmond J. W. Configurations of the Glycosidic Phosphates of Lipopolysaccharide from Salmonella minnesota R595. Biochemistry 1982; 21: 6580
   PubMedGoogle Scholar
• Mü Uhlradt P. F., Wray V., Lehman V. A 31P-Nuclear-Magnetic-Resonance Study of the Phosphate Groups in Lipopolysaccharide and Lipid A from Salmonella. Eur. J. Biochem. 1977; 81: 193
   PubMedGoogle Scholar
• Qureshi N., Takayama K., Heller D., Fenselau C. Position of Ester Groups in the Lipid A Backbone of Lipopolysaccharides Obtained from Salmonella typhimurium. J. Biol. Chem. 1983; 258: 12947
   PubMedGoogle Scholar
• Qureshi N., Mascagni P., Ribi E., Takayama K. Monophosphoryl Lipid A Obtained from Lipopolysaccharides of Salmonella minnesota R595: Purification of the Dimethyl Derivative by High Performance Liquid Chromatography and Complete Structural Determination. J. Biol. Chem. 1985; 260: 5271
   PubMed Web of Science ®Google Scholar
• Wollenweber H.-W., Broady K., Uderitz O., Rietschel E. T. The Chemical Structure of Lipid A: Demonstration of Amide-Linked 3-Acyloxyacyl Residues in Salmonella minnesota Re Lipopolysaccharide. Eur. J. Biochem. 1982; 124: 191
   PubMedGoogle Scholar
• Imoto M., Yoshimura N, Kusumoto S., Shiba T. Total Synthesis of Lipid A, Active Principle of Bacterial Endotoxin. Proc. Jpn. Acad. Ser. B 1984; 60: 285
   Google Scholar
• Kotani S., Takada H., Takahashi I., Tsukimoto M., Ogawa T., Ikeda T., Harada K., Okamura H., Tamura T, Tanaka S., Shiba T., Kusumoto S., Imoto M., Yoshimura H., Kasai N. Low Endotoxic Activities of Synthetic-Type Lipid A with an Additional Acyloxyacyl Group on the 2-Amino Group of β(1–6)Glucosamine disaccharide 1,4′-Bisphosphate. Infect. Immun. 1986; 52: 872
   PubMedGoogle Scholar
• Galanos C., Lü Uderitz O., Rietschel E., Westphal O., Brade H., Brade L., Freudenberg M., Schade U., Imoto M., Yoshimura H., Kusumoto S., Shiba S. Synthetic and Natural Escherichia coli Free Lipid A Express Identical Endotoxic Activities. Eur. J. Biochem. 1985; 148: 1
   PubMedGoogle Scholar
• Galanos C., Lü Uderitz O., Freudenberg M. A., Brade L., Schade U., Rietschel E. T., Kusumoto S., Shiba T. Biological Activity of Synthetic Heptaacyl Lipid A Representing a Component of Salmonella minnesota R595 Lipid A. Eur. J. Biochem. 1986; 160: 55
   PubMedGoogle Scholar
• Rietschel E. T., Brade L., Schade U., Seydel U., Zá Uhringer U., Lindner B., Moran A. P., Kulshin V. A., Haishima Y., Holst O., Andrzeweski E., Ulmer A. J., Flad H. D., Brade H. Endotoxin from Pathophysiology to Therapeutic Approaches, J. D. Baumgartner. Flammarion Médicine-Sciences, Paris 1990; 5
   Google Scholar
• Helander I. M., Lindner B., Brade H., Altmann K., Lindberg A. A., Rietschel E., Zá Uhringer U. Chemical Structure of the Lipopolysaccharide of Haemophilus influenzae Strain 1–69 Rd−/b+: Description of a Novel Deep-Rough Chemotype. Eur. J. Biochem. 1988; 177: 483
   PubMedGoogle Scholar
• Moran A., O'Malley D. T., Kosunen T. U., Helander I. M. Biochemical Characterization of Campylobacter fetus Lipopolysaccharide. Infect. Immun. 1994; 62: 3922
   PubMedGoogle Scholar
• Helander I., Kilpeläinen I, Vaara M., Moran A. P., Lindner B., Seydel U. Chemical Structure of the Lipid A Component of Lipopolysaccharides of the Genus Pectinatus. Eur. J. Biochem. 1994; 224: 63
   PubMedGoogle Scholar
• Sidorczyk Z., Zá Uhringer U., Rietschel E. T. Chemical Structure of the Lipid A Component of the Lipopolysaccharide from a Proteus mirabilis Re-Mutant. Eur. J. Biochem. 1983; 137: 15
   PubMedGoogle Scholar
• Basu S., Radziejewska-Lebrecht J., Mayer H. Lipopolysaccharide of Providencia rettgeri: Chemical Studies and Taxonomic Implications. Arch. Microbiol. 1986; 144: 213
   PubMedGoogle Scholar
• Masoud H., Weintraub S. T., Wang R., Cotter R., Holt S. C. Investigation of the Structure of Lipid A from Actinobacillus actinomycetemcomitans Strain Y4 and Human Clinical Isolate PO 1021–7. Eur. J. Biochem. 1991; 200: 775
   PubMedGoogle Scholar
• Hase S., Rietschel E. T. The Chemical Structure of the Lipid A Component of Lipopolysaccharides from Chromobacterium violaceum NCTC 9694. Eur. J. Biochem. 1977; 75: 23
   PubMedGoogle Scholar
• Tharanathan R. N., Salimath P. V., Weckesser J., Mayer H. The Structure of Lipid A from the Lipopolysaccharide of Rhodopseudomonas gelatinosa 29/1. Arch. Microbiol. 1985; 141: 279
   Google Scholar
• Masoud H., Lindner B., Weckesser J., Mayer H. The Structure of Lipid A Component of Rhodocyclus gelatinosus Dr, Lipopolysaccharide. System. Appl. Microbiol. 1990; 13: 227
   Google Scholar
• Bath U. R., Kontrohr T., Mayer H. Structure of Shigella sonnei Lipid A. FEMS Microbiol. Lett. 189; 40: 189
   Google Scholar
• Takayama K., Qureshi N., Hyver K., Honovich J., Cotter R. J., Mascagni P., Schneider H. Characterization of a Structural Series of Lipid A Obtained from the Lipopolysaccharides of Neisseria gonorrhoeae. J. Biol. Chem. 1986; 261: 10624
   PubMedGoogle Scholar
• Kulshin V., Zá Uhringer U., Lindner B., Frasch C. E., Tsai C.-M., Dmitriev B. A., Rietschel E. T. Structural Characterization of the Lipid A Component of Pathogenic Neisseria meningitidis. J. Bacteriol. 1992; 174: 1793
   PubMedGoogle Scholar
• Kulshin V., Zá Uhringer U., Lindner B., Uger K.-E., Dmitriev B. A., Rietschel E. T. Structural Characterization of the Lipid A Component of Pseudomonas aeruginosa Wild-Type and Rough Mutant Lipopolysaccharides. Eur. J. Biochem. 1991; 198: 697
   PubMedGoogle Scholar
• Rietschel E. T., Kirikae T., Schade F. U., Ulmer A. J., Holst O., Brade H., Schmidt G., Mamat U., Grimmecke H.-D., Kusumoto S., Zähringer U. The Chemical Structure of Bacterial Endotoxin in Relation to Bioactivity. Immunobiol. 1993; 187: 169
   PubMed Web of Science ®Google Scholar
• Helander I., Saukkonen K., Hakalehto E., Vaara M. Biological Activities of Lipopolysaccharides from Pectinatus cerevisiophilus. FEMS Microbiol. Lett. 1984; 24: 39
   Google Scholar
• Muotiala A., Helander I., Pyhälä L., Kosunen T. U., Moran A. P. Low Biological Activity of Helicobacter pylori Lipopolysaccharide. Infect. Immun. 1992; 60: 1714
   PubMed Web of Science ®Google Scholar
• Masoud H., Perry M. B., Richards J. C. Characterization of the Lipopolysaccharide of Moraxella catarrhalis: Structural Analysis of the Lipid A from McAtarrhalis Serotype A Lipopolysaccharide. Eur. J. Biochem. 1994; 220: 209
   PubMedGoogle Scholar
• Myers K. R., Truchot A. T., Ward J., Hudson Y., Ulrich J. T. Cellular and Molecular Aspects of Endotoxin Reactions, J. J. Spitzer, E. J. Ziegler. Elsevier Science Publishers B.V., Amsterdam, 145
   Google Scholar
• Weintraub A., Uhringer U., Wollenweber H.-W., Seydel U., Rietschel E. T. Structural Characterization of the Lipid A Component of Bacteroides fragilis NCTC 9343 lipopolysaccharide. Eur. J. Biochem. 1989; 183: 425
   PubMedGoogle Scholar
• Lindberg A. A., Weintraub A., Zá Uhringer U., Rietschel E. T. Structure Activity Relationship in Lipopolysaccharides of Bacteroides fragilis. Rev. Infect. Dis. 1990; 12: 133
   PubMedGoogle Scholar
• Salimath P. V., Weckesser J., Strittmatter W., Mayer H. Structural Studies on the Non-Toxic Lipid A from Rhodopseudomonas sphaeroides. Eur. J. Biochem. 1983; 136: 195
   PubMedGoogle Scholar
• Qureshi N., Honovich J. P., Hara H., Cotter R. J., Takayama K. Location of Fatty Acids in Lipid A Obtained from Lipopolysaccharide of Rhodopseudomonas sphaeroides ATCC 17023. J. Biol. Chem. 1988; 263: 5502
   PubMedGoogle Scholar
• Krauss J. H., Seydel U., Weckesser J., Mayer H. Structural Analysis of the Nontoxic Lipid A of Rhodobacter capsulatus 37b4. Eur. J. Biochem. 1989; 180: 519
   PubMedGoogle Scholar
• Ogawa T. Immunobiological Properties of Chemically Defined Lipid A from Lipopolysaccharide of Porphyromonas (Bacteroides) gingivalis. Eur. J. Biochem. 1994; 219: 737
   PubMedGoogle Scholar
• Ogawa T. Chemical Structure of Lipid A from Porphyromonas (Bacteroides) gingivalis Lipopolysaccharide. FEBS Lett. 1993; 332: 197
   PubMed Web of Science ®Google Scholar
• Rietschel E. T. Absolute Configuration of 3-Hydroxy Fatty Acids Present in Lipopolysaccharides from Various Bacterial Groups. Eur. J. Biochem. 1976; 64: 423
   PubMedGoogle Scholar
• Weckesser J., Mayer H. Different Lipid A Types in Lipopolysaccharides of Phototrophic and Related Non-Phototrophic Bacteria. FEMS Microbiol. Rev. 1988; 54: 143
   Google Scholar
• Moran A. P., Rietschel E. T., Kosunen T., Zá Uhringer U. Chemical Characterization of Campylobacter jejuni Lipopolysaccharides Containing N-Acetylneuraminic Acid and 2, 3-Diamino-2, 3-Dideoxy-D-Glucose. J. Bacteriol. 1991; 173: 618
   PubMed Web of Science ®Google Scholar
• Moran A., Zá Uhringer U., Seydel U., Scholz D., Utz P., Rietschel E. T. Structural Analysis of a Lipid A Component of Campylobacter jejuni CCUG 10936 (serotype 0:2) Lipopolysaccharide: Description of a Lipid A Containing a Hybrid Backbone of 2-Amino-2-Deoxy-D-Glucose and 2, 3-Diamino-2, 3-Dideoxy-D-Glucose. Eur. J. Biochem. 1991; 198: 459
   PubMedGoogle Scholar
• Moran A. P., Kosunen T. U., Brade L., Schade U., Rietschel E. T. Structural and Biological Investigations on the Lipid A Component of Campylobacter jejuni Lipopolysaccharides. Microb. Ecol. Health Dis. 1991; 4(Suppl.)S19
   Google Scholar
• Moran A. P., Kosunen T. U., Brade L., Brandenburg K., Zähringer U. Structural and Physical Investigations on the Inner Core-Lipid A Region of Campylobacter jejuni Lipopolysaccharides. Microb. Ecol. Health Dis. 1991; 4(Suppl.)S20
   Google Scholar
• Kasai N., Arata S., Mashimo J.-i., Akiyama Y., Tanaka C., Egawa K., Tanaka S. Pseudomonas diminuta LPS with a New Endotoxic Lipid A Structure. Biochem. Biophys. Res. Commun. 1987; 142: 972
   PubMedGoogle Scholar
• Kasai N., Arata S., Mashimo J.-I., Ohmori M., Mizutani T., Egawa K. Cellular and Molecular Aspects of Endotoxin Reactions, J. J. Spitzer, E. J. Ziegler. Elsevier Science Publishers B.V., Amsterdam 1990; 121
   Google Scholar
• Qureshi N., Takayama K., Seydel U., Wang R., Cotter R. J., Agrawal P. K., Bush C. A., Kurtz R., Berman D. T. Structural Analysis of the Lipid A Derived from the Lipopolysaccharide of Brucella abortus. J. Endotoxin Res. 1994; 1: 137
   Google Scholar
• Knirel Y. A., Lindner B., Rietschel E. T., Marre R., Sonesson A., Uhringer U. Study on Legionella pneumophila Serogroup 1 (Strain Phil. 1) Lipopolysaccharide: Part III. Investigation of the Lipid A Structure. J. Endotoxin Res. 1994; 1(Suppl.)53
   Google Scholar
• Galanos C, Roppel J., Weckesser J., Rietschel E. T., Mayer H. Biological Activities of Lipopolysaccharides and Lipid A from Rhodospirillaceae. Infect. Immun. 1977; 16: 407
   PubMedGoogle Scholar
• Weisshaar R., Lingens F. The Lipopolysaccharide of a Chloridazon-Degrading Bacterium. Eur. J. Biochem. 1983; 137: 155
   PubMedGoogle Scholar
• Hollingsworth R., Lill-Elghanian D. A. Isolation and Characterization of the Unusual Lipopolysaccharide Component, 2-Amino-2-Deoxy-2-N-(27-Hydroxyoctacosanoy1)-3–0-(3-Hydroxytetradecanoy1) -Gluco-Hexuronic Acid, and Its De-O-Acylation Product from the Free Lipid A of Rhizobium trifolii ANU843. J. Biol. Chem. 1989; 264: 14039
   PubMedGoogle Scholar
• Russa R., Lü Uderitz O., Rietschel E. T. Structural Analyses of Lipid A from Lipopolysaccharides of Nodulating and Non-Nodulating Rhizobium trifolii. Arch. Microbiol. 1985; 141: 284
   Google Scholar
• Urbanik-Sypniewska T., Seydel U., Greck M., Weckesser J., Mayer H. Chemical Studies on the Lipopolysaccharide of Rhizobium meliloti 10406 and Its Lipid A Region. Arch. Microbiol. 1989; 152: 527
   Google Scholar
• Hollingsworth R., Lill-Elghanian D. Endotoxin Research Series, Vol. 1: Cellular and Molecular Aspects of Endotoxin Reactions, J. J. Spitzer, E. J. Ziegler. Elsevier Science Publishers B.V., Amsterdam 1990; 73
   Google Scholar
• Tharnathan R. N., Weckesser J., Mayer H. Structural Studies on the D-Arabinose-Containing Lipid A from Rhodospirillum tenue 2761. Eur. J. Biochem. 1978; 84: 385
   PubMedGoogle Scholar
• Mayer H., Weckesser J. Handbook of Endotoxin, Vol. 1: Chemistry of Endotoxin, E. T. Rietschel. Elsevier Science Publishers B.V., Amsterdam 1984; 221
   Google Scholar
• Holst O., Borowiak D., Weckesser J., Mayer H. Structural Studies on the Phosphate-Free Lipid A of Rhodomicrobium vannielii ATCC 17100. Eur. J. Biochem. 1983; 137: 325
   PubMedGoogle Scholar
• Moran A. P., Helander I. M., Kosunen T. U. Compositional Analysis of Helicobacter pylori Rough-Form Lipopolysaccharides. J. Bacteriol. 1992; 174: 1370
   PubMed Web of Science ®Google Scholar
• Moran A. P., Helander I. M. Structural Basis Within Lipid A for Low Biological Activity of Helicobacter pylori Lipopolysaccharide. Ir. J. Med. Sci. 1992; 161(Suppl. 10)9
   PubMedGoogle Scholar
• Takayama K., Qureshi N. Bacterial Endotoxic Lipopolysaccharides, Vol. 1: Molecular Biochemistry and Cellular Biology, D. C. Morrison, J. L. Ryan. CRC Press, Boca Raton 1992; 43
   Google Scholar
• Kusumoto S. Bacterial Endotoxic Lipopolysaccharides, Vol. 1: Molecular Biochemistry and Cellular Biology, D. C. Morrison, J. L. Ryan. CRC Press, Boca Raton 1992; 81
   Google Scholar
• Stuetz P. L., Aschauer H., Hildebrandt J., Lam C., Loibner H., Macher I., Scholz D., Schuetze E., Vyplel H. Endotoxin Research Series, Vol. 1. Cellular and Molecular Aspects of Endotoxin Reactions, J. J. Spitzer, E. J. Ziegler. Elsevier Science Publishers B.V., Amsterdam 1990; 129
   Google Scholar
• Takada H., Kotani S. Bacterial Endotoxic Lipopolysaccharides, Vol. 1: Molecular Biochemistry and Cellular Biology, D. C. Morrison, J. L. Ryan. CRC Press, Boca Raton 1992; 107
   Google Scholar
• Kanegasaki S., Kojima Y., Matsuura M., Homma J. Y., Yamamoto A., Kumazawa Y., Tanamoto K.-I., Yasuda T., Tsumita T., Imoto M., Yoshimura H., Yamamoto M., Shimamoto T., Kusumoto S., Shiba T. Biological Activities of Analogues of Lipid A Based Chemically on the Revised Structural Model: Comparison of Mediator-Inducing, Immunomodulating and Endotoxic Activities. Eur. J. Biochem. 1984; 143: 237
   PubMedGoogle Scholar
• Kanegasaki S., Tanamoto K.-I., Yasuda T., Homma J. Y., Matsuura M., Nakatsuka M., Kumazawa Y., Yamamoto A., Shiba T., Kusumoto S., Imoto M., Yoshimura H., Shimamoto T. Structure-Activity Relationship of Lipid A: Comparison of Biological Activities of Natural and Synthetic Lipid A's with Different Fatty Acid Compositions. J. Biochem. (Tokyo) 1986; 99: 1203
   PubMedGoogle Scholar
• Loppnow H., Brade H., Dü Urrbaum I., Dinarello C. A., Kusumoto S., Rietschel E. T., Flad H. D. Interleukin 1 Induction-Capacity of Defined Lipopolysaccharide Partial Structures. J. Immunol. 1989; 142: 3229
   PubMed Web of Science ®Google Scholar
• Feist W., Musehold J., Brade H., Ulmer A. J., Kusumoto S., Flad H.-D. Induction of Tumor Necrosis Factor-Alpha Release by Lipopolysaccharide and Defined Lipopolysaccharide partial Structures. Immunobiol. 1989; 179: 293
   PubMedGoogle Scholar
• Wang M.-H., Flad H.-D., Feist W., Brade H., Kusumoto S., Rietschel E. T., Ulmer A. J. Inhibition of Endotoxin-Induced Interleukin-6 Production by Synthetic Lipid A Partial Structures in Human Peripheral Blood Mononuclear Cells. Infect. Immun. 1991; 59: 4655
   PubMedGoogle Scholar
• Feist W., Ulmer A. J., Wang M.-H., Musehold J., Schlü Uter C., Gerdes J., Herzbeck H., Brade H., Kusumoto S., Diamantstein T., Rietschel E. T., Flad H.-D. Modulation of Lipopolysaccharide-Induced Production of Tumor Necrosis Factor, Interleukin 1, and Interleukin 6 by Synthetic Precursor la of Lipid A, FEMS Microbiol. Immunol. 1992; 89: 73
   Google Scholar
• Shimizu T., Akiyama S., Masuzawa T., Yanagihara Y., Ikeda K., Takahashi T., Kondo H., Achiwa K. Biological Activities of Chemically Synthesized Proteus-Type Lipid A. Microbiol. Immunol. 1987; 31: 381
   PubMedGoogle Scholar
• Rietschel E. T., Brade L., Schade U., Galanos C., Freudenberg M., Lü Uderitz O., Kusumoto S., Shiba T. Endotoxic Properties of Synthetic Pentaacyl Lipid A lb and a Structural Isomer. Eur. J. Biochem. 1987; 169: 27
   PubMedGoogle Scholar
• Homma J. Y., Matsuura M., Kanegasaki S., Kawakubo Y., Kojima Y., Shibukawa N., Kumazawa Y., Yamamoto A., Tanamoto K.-i., Yasuda T., Imoto M., Yoshimura H., Kusumoto S., Shiba T. Structural Requirements of Lipid A Responsible for the Functions: A Study with Chemically Synthesized lipid A and its Analogues. J. Biochem. (Tokyo) 395; 98: 395
   Google Scholar
• Kotani S., Takada H., Tsujimoto M., Ogawa T., Takahashi I., Ikeda T., Otsuka K., Shimauchi H., Kasai N., Mashimo J., Nagao S., Tanaka A., Tanaka S., Harada K., Nagaki K., Kitamura H., Shiba T., Kusumoto S., Imoto M., Yoshimura H. Synthetic Lipid A with Endotoxic and Related Biological Activities Comparable to Those of a Natural Lipid A from an Escherichia coli Re-Mutant. Infect. Immun. 1985; 49: 225
   PubMed Web of Science ®Google Scholar
• Kotani S., Takada H., Takahashi I., Ogawa T., Masachika T., Shimauchi H., Ikeda T., Okamura H., Tamura T., Harada K., Tanaka S., Shiba T., Kusumoto S., Shimamoto T. Immunobiological Activities of Synthetic Lipid A Analogs with Low Endotoxicity. Infect. Immun. 1986; 54: 673
   PubMed Web of Science ®Google Scholar
• Kumazawa Y., Nakatsuka M., Takimoto H., Furuya T., Nagumo T., Yamamoto A., Homma J. Y., Inada K., Yoshida M., Kiso M., Hasegawa A. Importance of Fatty Acid Substituents of Chemically Synthesized Lipid A-Subunit Analogs in the Expression of Immunopharmacological Activity. Infect. Immun. 1988; 56: 149
   PubMed Web of Science ®Google Scholar
• Tanamoto K.-I. Free Hydroxyl Groups Are Not Required for Endotoxic Activity of Lipid A. Infect. Immun. 1994; 62: 1705
   PubMedGoogle Scholar
• Galanos C., Lehmann V., Lü Uderitz O., Rietschel E. T., Westphal O., Brade H., Brade L., Freudenberg M., Hansen-Hagge T., Lü Uderitz T., Mc Kenzie G., Schade U., Strittmatter W., Tanamoto K.-I., Zähringer U., Imoto M., Yoshimura H., Yamamoto M., Shimamoto T., Kusumoto S., Shiba T. Endotoxic Properties of Chemically Synthesized Lipid A Part Structures: Comparison of Synthetic lipid A Precursor and Synthetic Analogues with Biosynthetic Lipid A Precursor and Lipid A. Eur. J. Biochem. 1984; 140: 221
   PubMedGoogle Scholar
• Kotani S., Takada H., Tsuujimoto M., Ogawa T., Harada K., Mori Y., Kawasaki A., Tanaka A., Nagao S., Tanaka S., Shiba T., Kusumoto S., Imoto M., Yoshimura H., Yamamoto M., Shimamoto T. Immunobiologically Active Lipid A Analogs Synthesized According to a Revised Structural Model of Natural Lipid A. Infect. Immun. 1984; 45: 293
   PubMed Web of Science ®Google Scholar
• Takada H., Kotani S., Tsujimoto M., Ogawa T., Takahashi I., Harada K., Katsukawa C., Tanaka S., Shiba T., Kusumoto S., Imoto M., Yoshimura H., Yamamoto M., Shimamoto T. Immunopharmacological Activities of a Synthetic Counterpart of a Biosynthetic Lipid A Precursor Molecule and of Its Analogs. Infect. Immun. 1985; 48: 219
   PubMed Web of Science ®Google Scholar
• Ulmer A. J., Heine H., Feist W., Kusumoto S., Kusama T., Brade H., Schade U., Rietschel E. T., Flad H.-D. Biological Activity of Synthetic Phosphonoxyethyl Analogs of Lipid A and Lipid A Partial Structures. Infect. Immun. 1992; 60: 3309
   PubMed Web of Science ®Google Scholar
• Matsuura M., Kojima Y., Homma J. Y., Kubota Y., Yamamoto A., Kiso M., Hasegawa A. Biological Activities of Chemically Synthesized Analogues of the Nonreducing Sugar Moiety of Lipid A. FEBS Lett. 1984; 167: 226
   PubMed Web of Science ®Google Scholar
• Takahashi I., Kotani S., Takada H., Tsujimoto M., Ogawa T., Shiba Y., Kusumoto S., Yamamoto M., Hasegawa A., Kiso M., Nishijima M., Amano F., Akamatsu Y., Harada K., Takada S., Okamura H., Tamura T. Requirement of a Properly Acylated β(1–6)-D-Glucosamine Disaccharide Bisphosphate Structure for Efficient Manifestation of Full Endotoxic and Associated Bioactivities of Lipid A. Infect. Immun. 1987; 55: 57
   PubMedGoogle Scholar
• Aschauer H., Grob A., Hildebrandt J., Schuetze E., Stuetz P. Highly Purified Lipid X Is Devoid of Immunostimulatory Activity: Isolation and Characterization of Immunostimulating Contaminants in a Batch of Synthetic Lipid X. J. Biol. Chem. 1990; 265: 9159
   PubMedGoogle Scholar
• Kirikae T., Schade F., Zá Uhringer U., Kirikae F., Brade H., Kusumoto S., Kusama T., Rietschel E. T. The Significance of the Hydrophilic Backbone and the Hydrophobic Fatty Acid Regions of Lipid A for Macrophage Binding and Cytokine Induction. FEMS Immunol. Med. Microbiol. 1994; 8: 13
   PubMedGoogle Scholar
• Lü Uderitz T., Brandenburg K., Seydel U., Roth A., Galanos C., Rietschel E. T. Structural and Physicochemical Requirements of Endotoxins for the Activation of Arachidonic Acid Metabolism in Mouse Peritoneal Macrophages In Vitro. Eur. J. Biochem. 1989; 179: 11
   PubMedGoogle Scholar
• Morrison D. C., Ullevitch R. J. The Interaction of Bacterial Endotoxins with Cellular and Humoral Mediation Systems. Am. J. Pathol. 1978; 92: 527
   Google Scholar
• Ulevitch R. J. Recognition of Bacterial Endotoxins by Receptor-Dependent Mechanisms. Adv. Immunol. 1993; 53: 267
   PubMed Web of Science ®Google Scholar
• Mohler K. M., Sleath P. R., Fitzner J. N., Cerretti D. P., Alderson M., Kerwar S. S., Torrance D., Otten-Evans C., Greenstreet T., Weerawarna K., Kronheim S. R., Petersen M., Gerhart M., Kozlosky C. J., March C. J., Black R. A. Protection Against a Lethal Dose of Endotoxin by an Inhibitor of Tumour Necrosis Factor Processing. Nature (London) 1994; 370: 218
   PubMed Web of Science ®Google Scholar
• Okusawa S., Gelfand J. A., Ikejima T., Connolly R. J., Dinarello C. A. Interleukin 1 Induces a Shock-Like State in Rabbits: Synergism with Tumor Necrosis Factor and the Effect of Cyclooxygenase Inhibition. J. Clin. Invest. 1988; 81: 1162
   PubMed Web of Science ®Google Scholar
• Neta R., Sayers T., Oppenheim J. J. Tumor Necrosis Factor: Structure Function and Mechanism of Action, B. Marcel. Marcel Dekker, New York 1991; 499
   Google Scholar
• Warren H. S., Riveau G., Deckker F. A., Chedid L. A. Control of Endotoxin Activity and Interleukin-1 Production Through Regulation of Lipopolysaccharide-Lipoprotein Binding by a Macrophage Factor. Infect. Immun. 1988; 56: 204
   PubMed Web of Science ®Google Scholar
• Harris H. W., Grunfeld C., Feingold K. R., Rapp J. R. Human VLDL and Chylomicrons Can Protect Against Endotoxin-Induced Death in Mice. J. Clin. Invest. 1990; 86: 696
   PubMed Web of Science ®Google Scholar
• Marra M. N., Wilde C. G., Griffith J. E., Snable J. L., Scott R. W. Bactericidal/Permeability-Increasing Protein Has Endotoxin-Neutralizing Activity. J. Immunol. 1990; 144: 662
   PubMed Web of Science ®Google Scholar
• Weiss J., Victor M., Stendhal O., Elsbach P. Killing of Gram-Negative Bacteria by Polymorphonuclear Leukocytes: Role of an O2-Independent Bactericidal System. J. Clin. Invest. 1982; 69: 959
   PubMedGoogle Scholar
• Schumann R. R., Leong S. R., Flaggs G. W., Gray P. W., Wright S. D., Mathison J. C., Tobias P. S., Ulevitch R. J. Structure and Function of Lipopolysaccharide (LPS) Binding Protein: A Plasma Protein that Controls the Response of Macrophages to LPS. Science 1429; 249: 1429
   Google Scholar
• Tobias P. S., Soldau K., Ulevitch R. J. Identification of a Lipid A Binding Site in the Acute Phase Reactant Lipopolysaccharide Binding Protein. J. Biol. Chem. 1989; 264: 10867
   PubMed Web of Science ®Google Scholar
• Tobias P S, Mathison J C, Ulevitch R. J. A Family of Lipopolysaccharide Binding Proteins Involved in Responses to Gram-Negative Sepsis. J. Biol. Chem. 1988; 263: 13479
   PubMed Web of Science ®Google Scholar
• Heumann D., Gallay P., Betz-Corradin S., Barras C., Baumgartner J., Glauser M. P. Competition Between Bactericidal/Permeability-Increasing Protein and Lipopolysaccharide-Binding Protein for Lipopolysaccharide Binding to Monocytes. J. Infect. Dis. 1993; 167: 1351
   PubMedGoogle Scholar
• Wright S. D., Miller D., Leonard L. A., Calandra T., Wurfel M. Novel Plasma Proteins that Mediate Interaction of LPS with CD14. J. Cell Biochem. 1992; 16C(Suppl.)154
   Google Scholar
• Goyert S. M., Ferrero E. M., Seremetis S. V., Winchester R. J., Silver J., Mattison A. C. Biochemistry and Expression of Myelomonocytic Antigens. J. Immunol., 137: 3909
   PubMedGoogle Scholar
• Simmons D. L., Tan S., Tenen D., Nicholson-Weller A., Seed B. Monocyte Antigen CD14 Is a Phospholipid Anchored Membrane Protein. Blood 1989; 73: 284
   PubMed Web of Science ®Google Scholar
• Wright S. D., Ramos R. A., Tobias P. S., Ulevitch R. J., Mathison J. C. CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Proteins. Science 1990; 249: 1431
   PubMed Web of Science ®Google Scholar
• Mathison J. C., Tobias P. S., Wolfson E., Ulevitch R. J. Plasma Lipopolysaccharide (LPS)-Binding Protein. J. Immunol. 1992; 149: 200
   PubMed Web of Science ®Google Scholar
• Lee J.-D., Kato K., Tobias P. S., Kirkland T. N., Ulevitch R. J. Transfection of CD14 into 70Z/3 Cells Dramatically Enhances the Sensitivity to Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein. J. Exp. Med. 1992; 175: 1697
   PubMedGoogle Scholar
• Wright S. D. Multiple Receptors for Endotoxin. Curr. Opinion. Immunol. 1991; 3: 83
   PubMedGoogle Scholar
• Han J., Lee J.-D., Tobias P. S., Ulevitch R. J. Bacterial Lipopolysaccharide Induces Rapid Protein Tyrosine Phosphorylation in 70Z/3 Cells Expressing CD14. J. Biol. Chem. 1993; 268: 25009
   PubMedGoogle Scholar
• Weinstein S. L., June C., De Franco A. L. Lipopolysaccharide-Induced Protein Tyrosine Phosphorylation in Human Macrophages Is Mediated by CD14. J. Immunol. 1993; 151: 3829
   PubMed Web of Science ®Google Scholar
• Raetz C., Ulevitch R. J., Wright S. D., Sibley C. H., Ding A., Nathan C. F. Gram-Negative Endotoxin: An Extraordinary Lipid with Profound Effects on Eukaryotic Signal Transduction. FASEB J. 1991; 5: 2652
   PubMed Web of Science ®Google Scholar
• Kitchens R. L., Ulevitch R. J., Munford R. S. Lipopolysaccharide (LPS) Partial Structures Inhibit Responses to LPS in a Human Macrophage Cell Line Without Inhibiting LPS Uptake by a CD14-mediated pathway. J. Exp. Med. 1992; 176: 485
   PubMed Web of Science ®Google Scholar
• Lynn W. A., Raetz C., Qureshi N., Golenbock D. T. Lipopolysaccharide-Induced Stimulation of CD11b/CD18 Expression on Neutrophils. J. Immunol. 1991; 147: 3072
   PubMed Web of Science ®Google Scholar
• Hampton R. Y., Golenbock D. T., Penman M., Krieger M., Raetz C. R.H. Recognition and Plasma Clearance of Endotoxin by Scavenger Receptors. Nature (London) 1991; 352: 342
   PubMed Web of Science ®Google Scholar
• Peterson A. A., Munford R. S. Dephosphorylation of the Lipid A Moiety of Escherichia coli Lipopolysaccharide by Mouse Macrophages. Infect. Immunol. 1987; 55: 974
   PubMedGoogle Scholar
• Munford R. S., Hall C. L. Detoxification of Bacterial Lipopolysaccharides (Endotoxins) by a Human Neutrophil Enzyme. Science 1986; 234: 203
   PubMed Web of Science ®Google Scholar
• Luchi M., Munford R. S. Binding, Internalization, and Deacylation of Bacterial Lipopolysaccharides by Human Neutrophils. J. Immunol. 1993; 151: 959
   PubMed Web of Science ®Google Scholar
• Parillo J. E. Pathogenic Mechanisms of Septic Shock. New. Engl. J. Med. 1993; 328: 1471
   PubMed Web of Science ®Google Scholar
• Bone R. C. Gram-Negative Sepsis: a Dilemma of Modern Medicine. Clin. Microbiol. Rev. 1993; 6: 57
   PubMed Web of Science ®Google Scholar
• Davis J. New Approaches to Septic Shock. SCRIP 1993; 1793: 22
   Google Scholar
• Warren H. S., Danner R. L., Munford R. S. Anti-Endotoxin Monoclonal Antibodies. N. Engl. J. Med. 1992; 326: 1153
   PubMed Web of Science ®Google Scholar
• Cross A. S., Opal S. Therapeutic Intervention in Sepsis with Antibody to Endotoxin: Is There a Future?. J. Endotoxin Res. 1994; 1: 57
   Google Scholar
• Weiss J., Elsbach P., Shu C., Castillo J., Grinna L., Horwitz A., Theofan G. Human Bactericidal/ Permeability-Increasing Protein and a Recombinant NH2-Terminal Fragment Cause Killing of Serum-Resistant Gram-Negative Bacteria in Whole Blood and Inhibit Tumor Necrosis Factor Release Induced by the Bacteria. J. Clin. Invest. 1992; 90: 1122
   PubMed Web of Science ®Google Scholar
• Cohen J., Exley A. R., Buurman W., Owen R., Hanson G., Lumley J., Aulakh J. M., Bodmer M., Riddle A., Stephens S., Perry M. Monoclonal Antibody to TNF in Severe Septic Shock. Lancet 1990; 335: 1275
   PubMedGoogle Scholar
• Arend W. P. Interleukin 1 Receptor Antagonist: a New Member of the Interleukin 1 Family. J. Clin. Invest. 1991; 88: 1445
   PubMed Web of Science ®Google Scholar
• Golenbock D. T., Hampton R. Y., Qureshi N., Takayama K., Raetz C. R.H. Lipid A-Like Molecules that Antagonize the Effects of Endotoxins on Human Monocytes. J. Biol. Chem. 1991; 266: 19490
   PubMed Web of Science ®Google Scholar
• Takayama K., Qureshi N., Beutler B., Kirkland T. N. Diphosphoryl Lipid A from Rhodopseudomonas sphaeroides ATCC 17023 Blocks Induction of Cachectin in Macrophages by Lipopolysaccharide. Infect. Immun. 1989; 57: 1336
   PubMed Web of Science ®Google Scholar
• Christ W. J., Kawata T., Hawkins L. D., Kobayashi S., Asano O., Rossignol D. P. European Patent 0–536-969-A2. 1993
   Google Scholar
• Westphal O. Endotoxin Research Series, Vol. 2: Bacterial Endotoxin - Recognition and Effector Mechanisms, C. R. Alving, R. S. Munford, P. L. Stutz. Elsevier Science Publishers B.V., Amsterdam 1993; 17
   Google Scholar
• Pece S., Jirillo E., Giuilani G., Petruzelli R., Fumarola D., Moran A. P. Immunological and Toxic Effects of Diverse Helicobacter pylori R-LPS and Lipid A Chemotypes. J. Endotoxin Res. 1994; 1(Suppl.)39
   Google Scholar
• Pece S., Montemurro P., Piccoli C., Muolo V., Colucci M., Fumarola D., Semeraro N., Moran A. P. Induction of Tissue Factor and Plasminogen Activator Inhibitor Type 2 in Mononuclear Leukocytes by Helicobacter pylori Lipopolysaccharide (LPS). J. Endotoxin Res. 1994; 1(Suppl.)85
   Google Scholar
• Nielsen H., Birkholz S., Andersen L. P., Moran A. P. Neutrophil Activation by Helicobacter pylori Lipopolysaccharides. J. Infect. Dis. 1994; 170: 135
   PubMed Web of Science ®Google Scholar